UK markets open in 4 hours 3 minutes

FHTX Jun 2024 2.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 04:34PM EDT. Market open.
Full screen
Previous close0.0500
Open0.0500
Bid0.0000
Ask0.6500
Strike2.50
Expiry date2024-06-21
Day's range0.0500 - 0.0500
Contract rangeN/A
Volume1
Open interest3
  • GlobeNewswire

    Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June

    CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced management's participation in the Jefferies Global Healthcare Conference and the Goldman Sachs 45th Annual Global Healthcare Conference. With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have

  • GlobeNewswire

    Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline

    Positions company to further leverage strength of platform and advance programs through multiple data readouts and clinical value inflection points Strengthens balance sheet with cash, cash equivalents and short-term investments of $310 million and extends cash runway into 2027 CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal g

  • GlobeNewswire

    Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants

    CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (“Foghorn”) (Nasdaq: FHTX) today announced the pricing of a registered direct offering of 12,743,039 shares of its common stock at a price of $5.51 per share, before underwriting discounts and commissions, and in lieu of common stock to certain investors, pre-funded warrants to purchase up to an aggregate of 7,220,794 shares of its common stock at a price of $5.5099 per pre-funded warrant, which represents the per share